Genetic Analysis AS reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 3.8 million compared to NOK 3.47 million a year ago. Revenue was NOK 6.37 million compared to NOK 5.67 million a year ago. Net loss was NOK 6.67 million compared to NOK 7.8 million a year ago. Basic loss per share from continuing operations was NOK 0.17 compared to NOK 0.31 a year ago. Diluted loss per share from continuing operations was NOK 0.17 compared to NOK 0.31 a year ago.
For the full year, sales was NOK 14.15 million compared to NOK 11.16 million a year ago. Revenue was NOK 23.16 million compared to NOK 20.75 million a year ago. Net loss was NOK 23.82 million compared to NOK 28.27 million a year ago. Basic loss per share from continuing operations was NOK 0.62 compared to NOK 1.13 a year ago. Diluted loss per share from continuing operations was NOK 0.62 compared to NOK 1.13 a year ago.